Viral pneumonia with other viruses besides COVID-19 <br/ >Patients are not suitable for immunoglobulin therapy. <br/ >Patients with severe pneumonia defined as : RR â?¥ 30 times/min or oxygen saturation â?¤ 90% in resting state or PaO2/FiO2 â?¤ 100 mmHg or respiratory failure and mechanical ventilation are required or shock occurs or ICU monitoring with prescence of other organ failure. <br/ >Patients on either immunoglobulin or hydroxychloroquine treatment <br/ >Pregnant or lactating women or other circumstances in which the investigator determined that the patient is not suitable for the clinical trial. <br/ >Participation in other studies. <br/ >

Viral pneumonia with other viruses besides COVID-19 <br/ >Patients are not suitable for immunoglobulin therapy. <br/ >Patients with severe pneumonia defined as : RR â?¥ 30 times/min or oxygen saturation â?¤ 90% in resting state or PaO2/FiO2 â?¤ 100 mmHg or respiratory failure and mechanical ventilation are required or shock occurs or ICU monitoring with prescence of other organ failure. <br/ >Patients on either immunoglobulin or hydroxychloroquine treatment <br/ >Pregnant or lactating women or other circumstances in which the investigator determined that the patient is not suitable for the clinical trial. <br/ >Participation in other studies. <br/ >

N/A

N/A

Viral pneumonia with other viruses besides COVID-19 <br/ >Patients are not suitable for immunoglobulin therapy. <br/ >Patients with severe pneumonia defined as : RR â?¥ 30 times/min or oxygen saturation â?¤ 90% in resting state or PaO2/FiO2 â?¤ 100 mmHg or respiratory failure and mechanical ventilation are required or shock occurs or ICU monitoring with prescence of other organ failure. <br/ >Patients on either immunoglobulin or hydroxychloroquine treatment <br/ >Pregnant or lactating women or other circumstances in which the investigator determined that the patient is not suitable for the clinical trial. <br/ >Participation in other studies. <br/ >

Viral pneumonia with other viruses besides COVID-19 <br/ >Patients are not suitable for immunoglobulin therapy. <br/ >Patients with severe pneumonia defined as : RR â?¥ 30 times/min or oxygen saturation â?¤ 90% in resting state or PaO2/FiO2 â?¤ 100 mmHg or respiratory failure and mechanical ventilation are required or shock occurs or ICU monitoring with prescence of other organ failure. <br/ >Patients on either immunoglobulin or hydroxychloroquine treatment <br/ >Pregnant or lactating women or other circumstances in which the investigator determined that the patient is not suitable for the clinical trial. <br/ >Participation in other studies. <br/ >